Cancer vaccines poised to unlock ' new treatment paradigm ' with Merck/Moderna data

Adding an experimental mRNA-based vaccine from (NASDAQ: ) Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a mid-stage trial, the companies reported on Monday. With this and earlier data, Moderna is considering…#incandmerckco #moderna #stephenhoge #merck #keytruda #janehealy #merckmoderna #gritstonebioinc #roche #tecentriq
Source: Reuters: Health - Category: Consumer Health News Source Type: news